CD4 and neoplasm: In a recent study reported by Rezaei et al, DEXs loaded with miR-124-3p mimics reduced the CD4+/CD8+ cell ratio and FOXP3+ Treg/CD8+ cells ratio in tumor tissue, eliciting stronger tumor immunosuppression (205).